Delivery Order SPE2DB24D8003-SPE2DB25FJVEB
- Not listed
- The Defense Logistics Agency awarded a delivery order to Dakota Drug, Inc., a small disadvantaged business based in Anoka, Minnesota, for the supply of Methylphenidate ER 18 mg tablets (100-count units) valued at $3,142.26. This firm fixed-price delivery order was issued on July 31, 2025, with an ultimate completion date of August 1, 2025, and carries no set-aside designation. The award falls under Dakota Drug's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical's ECAT...
- The Defense Logistics Agency awarded a delivery order valued at $6,888.57 to Dakota Drug, Inc., a small disadvantaged business based in Anoka, Minnesota, for the supply of Methylphenidate ER 36 mg tablets in quantities of 100. This firm fixed-price delivery order, awarded on August 28, 2025, represents a single pharmaceutical supply requirement with a completion date of August 29, 2025. The award carries no set-aside designation and is being performed at the vendor's location in Anoka,...
- The Defense Logistics Agency awarded a $6,953.25 firm fixed-price delivery order to Dakota Drug, Inc., a small disadvantaged business based in Anoka, Minnesota, for the supply of Methylphenidate ER 54 mg tablets in quantities of 100 units. The contract, awarded on September 18, 2025, with an ultimate completion date of September 19, 2025, represents a continuation of pharmaceutical supply services under the company's larger indefinite delivery contract with DLA Troop Support Medical. This...
- The Defense Logistics Agency (DLA) awarded a delivery order to Dakota Drug, Inc., a small disadvantaged business based in Anoka, Minnesota, for the supply of Methylphenidate ER 54 mg tablets (100 count) with a ceiling value of $2,055.10. This firm fixed price delivery order was issued on July 22, 2025, with an ultimate completion date of July 23, 2025, with no set-aside designation applied. The contract represents a direct fulfillment of pharmaceutical supply requirements under Dakota Drug's...
- Dakota Drug, Inc., a self-certified small disadvantaged business based in Anoka, Minnesota, was awarded a delivery order by the Defense Logistics Agency (DLA) on August 13, 2025, for the supply of Methylphenidate ER 36 mg tablets in quantities of 100 units. This firm fixed-price delivery order, valued at $6,484.12, is scheduled for completion by August 14, 2025, and represents performance work to be conducted at the contractor's Anoka, Minnesota location. The award utilized no set-aside...
- The Defense Logistics Agency awarded a $4.45K firm fixed-price delivery order to Dakota Drug, Inc., a small disadvantaged business based in Anoka, Minnesota, for the supply of Methylphenidate ER 27 mg tablets (100-count units). The contract, executed on August 12, 2025, with an ultimate completion date of August 13, 2025, represents a delivery order under Dakota Drug's larger Indefinite Delivery Contract (SPE2DB24D8001) valued at $999.99M with DLA Troop Support Medical's ECAT Generation V...
- The Defense Logistics Agency awarded a delivery order to Dakota Drug, Inc., a small disadvantaged business based in Anoka, Minnesota, for the supply of Methylphenidate ER(LA) 20mg in quantities of 100 units. This firm fixed-price delivery order, valued at $2,023.94, was issued on August 27, 2025, with an ultimate completion date of August 28, 2025. The award carries no set-aside designation and represents a direct procurement from the federal marketplace to support U.S. Armed Forces medical...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $8,246.04 to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota, for the supply of Methylphenidate ER 54 mg tablets (100-count bottles). This unrestricted, non-set-aside contract was awarded on August 25, 2025, with an ultimate completion date of August 26, 2025, and represents a delivery order under the company's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency (DLA) awarded a $4,598.25 delivery order to Dakota Drug, Inc., a self-certified small disadvantaged business based in Anoka, Minnesota, for the supply of Methylphenidate ER 27 mg tablets (100-count units). The contract, awarded on July 23, 2025, with an ultimate completion date of July 24, 2025, operates under a firm fixed-price structure with no set-aside designation. This delivery order is issued under Dakota Drug, Inc.'s larger Indefinite Delivery Contract...
- This federal contract award is for the delivery of Methylphenidate ER 36 mg tablets in 100-count packages to the Defense Logistics Agency (DLA). The $3,362.34 firm fixed-price delivery order was awarded to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The award is not set-aside and has an ultimate completion date of May 28, 2025. Dakota Drug, Inc. holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA as part of the...
- SPE2DB24D8003Indefinite Delivery Contract
- SPE2DB24D8003-SPE2DB25FJVEBDelivery Order
The Defense Logistics Agency awarded a delivery order to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota, for the supply of Methylphenidate ER 36 mg tablets (100 count) valued at $12,216.10. This is a firm fixed-price delivery order with no set-aside designation, awarded on September 4, 2025, with an ultimate completion date of September 5, 2025. The contract performance location is in Anoka, Minnesota, where Dakota Drug maintains its operations. This delivery order falls under Dakota Drug's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical's ECAT Generation V Program, valued at $999,999,999.00 and extending through December 31, 2025. Dakota Drug has established itself as a critical pharmaceutical supplier to the Defense Logistics Agency, providing a comprehensive range of medications and medical supplies to support U.S. Armed Forces medical operations. The company's extensive federal contracting history demonstrates its capability to deliver diverse pharmaceutical products, including neurological prescriptions, pain management drugs, and other critical medications necessary for military healthcare facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.2k | 9/4/25 |